Somerman Martha J. Dds, Phd - Net Worth and Insider Trading

Somerman Martha J. Dds, Phd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Somerman Martha J. Dds, Phd owns 1 companies in total, including Biolase Inc (BIOL) .

Click here to see the complete history of Somerman Martha J. Dds, Phd’s form 4 insider trades.

Insider Ownership Summary of Somerman Martha J. Dds, Phd

Ticker Comapny Transaction Date Type of Owner
BIOL Biolase Inc 2021-08-12 director

Somerman Martha J. Dds, Phd Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Somerman Martha J. Dds, Phd Ownership Network

Ownership Network List of Somerman Martha J. Dds, Phd

No Data

Ownership Network Relation of Somerman Martha J. Dds, Phd

Insider Network Chart

Somerman Martha J. Dds, Phd Owned Company Details

What does Biolase Inc do?

Who are the key executives at Biolase Inc?

Somerman Martha J. Dds, Phd is the director of Biolase Inc. Other key executives at Biolase Inc include 10 percent owner Goldman Sachs Group Inc , 10 percent owner Goldman Sachs & Co. Llc , and Chief Financial Officer Jennifer Bright .

Biolase Inc (BIOL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Biolase Inc (BIOL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biolase Inc (BIOL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Biolase Inc (BIOL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biolase Inc Insider Transactions

No Available Data

Somerman Martha J. Dds, Phd Mailing Address

Above is the net worth, insider trading, and ownership report for Somerman Martha J. Dds, Phd. You might contact Somerman Martha J. Dds, Phd via mailing address: 27042 Town Centre Drive, Suite 270, Foothill Ranch Ca 92610.

Discussions on Somerman Martha J. Dds, Phd

No discussions yet.